SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Janssen Pharmaceutica N.V. Release: INCIVO ® (Telaprevir) in Combination With Peginterferon Alfa and Ribavirin is Cost-effective for Both Treatment-naïve and Experienced Patients With Chronic Genotype-1 Hepatitis C Virus